Although originally developed for the treatment of metabolic diseases, GLP-1-based therapies are now recognized for their influence on the same brain systems mediating drug-seeking and reward, suggesting therapeutic potential beyond glycemic control
E., Schweizer, A., Couturier, A
Derfor m de ofte injiseres for ha effekt, og da omfattes de av legemiddelregelverket
For instance, while cyclic peptides like CyRL-QN15 gain enzymatic resistance through rigid structures [84], tripeptides such as GHK maintain therapeutic potency while being more adaptable and versatile in formulation
That results not only in significant weight loss, but improved health markers